| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA4569894
Max Phase: Preclinical
Molecular Formula: C24H30N2O2
Molecular Weight: 378.52
Molecule Type: Unknown
Associated Items:
Representations
Canonical SMILES: CC1=C(C(=O)Nc2ccccc2C)C(C2CCCCC2)C2=C(CCCC2=O)N1
Standard InChI: InChI=1S/C24H30N2O2/c1-15-9-6-7-12-18(15)26-24(28)21-16(2)25-19-13-8-14-20(27)23(19)22(21)17-10-4-3-5-11-17/h6-7,9,12,17,22,25H,3-5,8,10-11,13-14H2,1-2H3,(H,26,28)
Standard InChI Key: MMVARQHHYCVVFU-UHFFFAOYSA-N
Associated Targets(Human)
Free fatty acid receptor 3 304 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 378.52 | Molecular Weight (Monoisotopic): 378.2307 | AlogP: 5.01 | #Rotatable Bonds: 3 |
| Polar Surface Area: 58.20 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 2 |
| #RO5 Violations: 1 | HBA (Lipinski): 4 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 1 |
| CX Acidic pKa: | CX Basic pKa: 0.30 | CX LogP: 4.18 | CX LogD: 4.18 |
| Aromatic Rings: 1 | Heavy Atoms: 28 | QED Weighted: 0.78 | Np Likeness Score: -1.01 |
References
| 1. Ulven ER, Quon T, Sergeev E, Barki N, Brvar M, Hudson BD, Dutta P, Hansen AH, Bielefeldt LØ, Tobin AB, McKenzie CJ, Milligan G, Ulven T.. (2020) Structure-Activity Relationship Studies of Tetrahydroquinolone Free Fatty Acid Receptor 3 Modulators., 63 (7): [PMID:32141297] [10.1021/acs.jmedchem.9b02036] |
Source
Source(1):